Groupe Guillin SA:企業の戦略・SWOT・財務情報

◆英語タイトル:Groupe Guillin SA - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C1901
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:紙・包装
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Groupe Guillin SA – Strategy, SWOT and Corporate Finance Report
Summary

Groupe Guillin SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Groupe Guillin SA (Guillin) produces and markets thermoformed plastic packaging products. The company designs, develops and manufactures plastic packaging products. Its product portfolio includes trays, sealed food containers, dishes, and plates. The company offers food packaging products to fruit and vegetable producers, bakeries, supermarkets, hypermarkets and fresh food outlets. The company also provides packaged delivery equipment including cold packs, reheating ovens, food distribution and reheating carts, washing chambers and serves to hospitals, schools and prisons. Through the subsidiaries the company carries out operations across European countries including France, Poland, Germany, Italy, Spain and the UK. Guillin is headquartered in Ornans, France.

Scope

- Detailed information on Groupe Guillin SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Groupe Guillin SA in the form of a SWOT analysis
- An in-depth view of the business model of Groupe Guillin SA including a breakdown and examination of key business segments
- Intelligence on Groupe Guillin SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Groupe Guillin SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Groupe Guillin SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Groupe Guillin SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Groupe Guillin SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Groupe Guillin SA: Company Overview 7
Groupe Guillin SA: Overview and Key Facts 7
Groupe Guillin SA: Overview 7
Groupe Guillin SA: Key Facts 7
Groupe Guillin SA: Key Employees 9
Groupe Guillin SA: Major Products and Services 10
Groupe Guillin SA: Company History 12
Groupe Guillin SA: Management Statement 14
Groupe Guillin SA: Locations and Subsidiaries 15
Groupe Guillin SA: Key Competitors 17
Groupe Guillin SA: Company Analysis 18
Groupe Guillin SA: Business Description 18
Groupe Guillin SA: SWOT Analysis 19
Groupe Guillin SA: SWOT Overview 19
Groupe Guillin SA: Strengths 19
Groupe Guillin SA: Weaknesses 20
Groupe Guillin SA: Opportunities 20
Groupe Guillin SA: Threats 20
Groupe Guillin SA: Corporate Financial Deals Activity 22
Groupe Guillin SA: Financial Deals Overview 22
Groupe Guillin SA: Targets and Partners 23
Groupe Guillin SA: Top Deals 2014 – 2018YTD* 24
Groupe Guillin SA: Mergers and Acquisitions 25
Appendix 26
Contact Us 26
Methodology 26
About MarketLine 27

List of Tables
Table 1: Groupe Guillin SA: Key Facts
Table 2: Groupe Guillin SA: Key Employees
Table 3: Groupe Guillin SA: Locations and Subsidiaries
Table 4: Groupe Guillin SA: Key Competitors
Table 5: Groupe Guillin SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Groupe Guillin SA: Targets and Partners
Table 7: Groupe Guillin SA: Top Deals 2014 - 2018YTD*
Table 8: Groupe Guillin SA: M&A Volume and Value Trend (2014 - YTD*2018)
Table 9: Groupe Guillin SA: M&A Activity by Geography (2014 - YTD*2018)

List of Figures
Figure 1: Groupe Guillin SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Groupe Guillin SA: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 3: Groupe Guillin SA: M&A Activity by Geography (2014 - YTD*2018)

★海外企業調査レポート[Groupe Guillin SA:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Toyota Tsusho Corp (8015):電力:M&Aディール及び事業提携情報
    Summary Toyota Tsusho Corp (Toyota Tsusho) is a diversified general trading and project management company. The company trades steel, aluminum, machinery, electronics, energy, chemicals, and other consumer products. It also provides passenger cars, buses, motorcycles, trucks, used vehicles, electron …
  • Shopper’S Stop Ltd.:企業の戦略・SWOT・財務分析
    Shopper'S Stop Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shopper'S Stop Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cereno Scientific AB (CRNO TO):製薬・医療:M&Aディール及び事業提携情報
    Summary Cereno Scientific AB (Cereno Scientific) is a developer of preventive drugs that normalize the body's own defense system against blood clots. The company develops drugs in the therapeutic area of thrombosis-related cardiovascular diseases. Its lead product candidate CS1 is being developed fo …
  • Langley Holdings plc:企業の戦略・SWOT・財務分析
    Langley Holdings plc - Strategy, SWOT and Corporate Finance Report Summary Langley Holdings plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • PPL Corp:企業の発電所・SWOT分析2018
    PPL Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executive …
  • Noerr LLP:企業の戦略的SWOT分析
    Noerr LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Sterling Bank Plc
    Sterling Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Sterling Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • InVivoScribe Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary InVivoScribe Technologies Inc (InVivoScribe) is a provider of hematology-oncology testing products and services. The company’s products include lymphotrack and lymphotrack DX assay kits, and custom assay and reagent development products. It also provides general purpose reagents such as PCR …
  • Cadila Healthcare Ltd (CADILAHC):製薬・医療:M&Aディール及び事業提携情報
    Summary Cadila Healthcare Ltd (Zydus Cadila) is an integrated, global healthcare provider. It discovers, develops, manufactures and markets various healthcare products. The company’s product portfolio includes active pharmaceutical ingredients (APIs), formulations, wellness and animal health product …
  • Nitto Denko Corporation:企業の戦略・SWOT・財務分析
    Nitto Denko Corporation - Strategy, SWOT and Corporate Finance Report Summary Nitto Denko Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Orbis Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Orbis Biosciences Inc (Orbis) is a developer of pharmaceutical products that offers optimizes oral and injectable products. The company provides preclnical pipeline indications for pathologies including cancer, bronchiolitis, Eczema, atopic dermatitis, nephrotic syndrome, HIV, asthma, bunine …
  • University of York-製薬・医療分野:企業M&A・提携分析
    Summary University of York (York) is an educational and research university that offers academic research and teaching services. The university offers commercial facilities and services, funding collaborative research, knowledge transfer partnerships, professional development and training, consultan …
  • Ur-Energy Inc. (URE):企業の財務・戦略的SWOT分析
    Ur-Energy Inc. (URE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • SpringWorks Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary SpringWorks Therapeutics LLC (SpringWorks Therapeutics) is a drug development company that develops therapeutic medicines for various diseases. The company’s pipeline products include Nirogacestat, MEK ½ Inhibitor, Senicapoc and FAAH Inhibitor. Its Nirogacestat is a gamma secretase inhibitor …
  • Span-America Medical Systems Inc (SPAN):企業の財務・戦略的SWOT分析
    Summary Span-America Medical Systems Inc (Span-America), a subsidiary of Savaria Corp, is a medical device company that designs and manufactures pressure management and patient positioning products. The company offers products such as surfaces, seat cushions, patient positioners, skin care products, …
  • Savara Inc (SVRA):医療機器:M&Aディール及び事業提携情報
    Summary Savara Inc (Savara) formerly Mast Therapeutics Inc is a clinical stage biopharmaceutical company, which develops therapies for the treatment of rare respiratory diseases, including cystic fibrosis (CF), and pulmonary alveolar proteinosis (PAP). The company’s lead product candidates include M …
  • Fichtner GmbH & Co KG:企業の戦略的SWOT分析
    Fichtner GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Accenture plc:企業の戦略・SWOT・財務分析
    Accenture plc - Strategy, SWOT and Corporate Finance Report Summary Accenture plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Aeroflot Oao
    Aeroflot Oao - Strategy, SWOT and Corporate Finance Report Summary Aeroflot Oao - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Response Biomedical Corp:医療機器:M&Aディール及び事業提携情報
    Summary Response Biomedical Corp (Response Biomedical) focuses on the research, development, manufacture and marketing of diagnostic technologies for the point-of-care (POC), central-lab testing and on-site environmental testing markets. It offers Cardiovascular tests such as Troponin-I, Myoglobin, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆